Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 SAD and MAD Study of LIFE-001 in Healthy Volunteers
NCT06904807Phase 1Recruiting
- Sponsor
- LifeMine Therapeutics
- Start
- Apr 2025
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of LIFE-001 (4 arms), sponsored by LifeMine Therapeutics. Primary endpoint: Adverse Events at Day 56. Started Apr 2025; status: recruiting.
02
Drugs
LIFE-001
Beyond the preview
Go deeper on NCT06904807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06904807.